237 related articles for article (PubMed ID: 12356640)
1. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
[TBL] [Abstract][Full Text] [Related]
2. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.
Singh I; Burnand KG; Collins M; Luttun A; Collen D; Boelhouwer B; Smith A
Circulation; 2003 Feb; 107(6):869-75. PubMed ID: 12591758
[TBL] [Abstract][Full Text] [Related]
3. [Urokinase stimulates whereas tissue plasminogen activator attenuates blood vessel stenosis].
Plekhanova OS; Solomatina MA; Domogatskiĭ SP; Naumov VG; Tkachuk VA; Parfenova EV; Chazov EI
Ross Fiziol Zh Im I M Sechenova; 2001 May; 87(5):584-93. PubMed ID: 11452792
[TBL] [Abstract][Full Text] [Related]
4. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
5. Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms.
Plekhanova O; Parfyonova Y; Bibilashvily R; Domogatskii S; Stepanova V; Gulba DC; Agrotis A; Bobik A; Tkachuk V
Atherosclerosis; 2001 Dec; 159(2):297-306. PubMed ID: 11730809
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
8. Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator.
Montesinos MC; Desai-Merchant A; Cronstein BN
Inflammation; 2015 Dec; 38(6):2036-41. PubMed ID: 25991438
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
Zhu Y; Carmeliet P; Fay WP
Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury.
Parfyonova Y; Plekhanova O; Solomatina M; Naumov V; Bobik A; Berk B; Tkachuk V
J Vasc Res; 2004; 41(3):268-76. PubMed ID: 15192267
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice.
Martin-McNulty B; Zhang L; da Cunha V; Vincelette J; Rutledge JC; Vergona R; Sullivan ME; Wang YX
Transl Res; 2007 Feb; 149(2):70-5. PubMed ID: 17240317
[TBL] [Abstract][Full Text] [Related]
12. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
13. The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.
Kawao N; Tamura Y; Horiuchi Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
PLoS One; 2015; 10(4):e0123982. PubMed ID: 25893677
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice.
Cooper JM; Rastogi A; Krizo JA; Mintz EM; Prosser RA
Eur J Neurosci; 2017 Mar; 45(6):805-815. PubMed ID: 27992087
[TBL] [Abstract][Full Text] [Related]
15. Expression of the plasminogen activator system in the human vascular wall.
Salame MY; Samani NJ; Masood I; deBono DP
Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
[TBL] [Abstract][Full Text] [Related]
16. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.
Rakic JM; Lambert V; Munaut C; Bajou K; Peyrollier K; Alvarez-Gonzalez ML; Carmeliet P; Foidart JM; Noël A
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1732-9. PubMed ID: 12657615
[TBL] [Abstract][Full Text] [Related]
17. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
Jögi A; Rønø B; Lund IK; Nielsen BS; Ploug M; Høyer-Hansen G; Rømer J; Lund LR
PLoS One; 2010 Sep; 5(9):e12746. PubMed ID: 20856796
[TBL] [Abstract][Full Text] [Related]
18. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.
Hijazi N; Abu Fanne R; Abramovitch R; Yarovoi S; Higazi M; Abdeen S; Basheer M; Maraga E; Cines DB; Higazi AA
Blood; 2015 Apr; 125(16):2558-67. PubMed ID: 25673638
[TBL] [Abstract][Full Text] [Related]
19. c-Myc is essential for urokinase plasminogen activator expression on hypoxia-induced vascular smooth muscle cells.
Hou Y; Okamoto C; Okada K; Kawao N; Kawata S; Ueshima S; Matsuo O
Cardiovasc Res; 2007 Jul; 75(1):186-94. PubMed ID: 17382917
[TBL] [Abstract][Full Text] [Related]
20. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
